UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Viral Mutation Rates

Journal of Virology, 2010-10, Vol.84 (19), p.9733-9748

2010

Volltextzugriff (PDF)

Exploiting Drug Repositioning for Discovery of a Novel HIV Combination Therapy

Journal of Virology, 2010-09, Vol.84 (18), p.9301-9309

2010

Volltextzugriff (PDF)

The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations

Viruses, 2018-07, Vol.10 (7), p.376

2018

Volltextzugriff (PDF)

Development of a User-Friendly Pipeline for Mutational Analyses of HIV Using Ultra-Accurate Maximum-Depth Sequencing

Viruses, 2021-07, Vol.13 (7), p.1338

2021

Volltextzugriff (PDF)

Vpr-mediated Incorporation of UNG2 into HIV-1 Particles Is Required to Modulate the Virus Mutation Rate and for Replication in Macrophages

The Journal of biological chemistry, 2004-07, Vol.279 (27), p.28419-28425

2004

Volltextzugriff (PDF)

Retroviral vectors for analysis of viral mutagenesis and recombination

Viruses, 2014-09, Vol.6 (9), p.3612-3642

2014

Volltextzugriff (PDF)

Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2

Journal of molecular biology, 2022-01, Vol.434 (2), p.167355-167355, Article 167355

2022

Volltextzugriff (PDF)

Structural Insights into the Mechanism of Human T-cell Leukemia Virus Type 1 Gag Targeting to the Plasma Membrane for Assembly

Journal of molecular biology, 2021-09, Vol.433 (19), p.167161-167161, Article 167161

2021

Volltextzugriff (PDF)

Influence of Reverse Transcriptase Variants, Drugs, and Vpr on Human Immunodeficiency Virus Type 1 Mutant Frequencies

Journal of Virology, 2003-02, Vol.77 (3), p.2071-2080

2003

Volltextzugriff (PDF)

Interrelationship between HIV-1 Fitness and Mutation Rate

Journal of molecular biology, 2013-01, Vol.425 (1), p.41-53

2013

Volltextzugriff (PDF)

Back to the future: revisiting HIV-1 lethal mutagenesis

Trends in microbiology (Regular ed.), 2013-02, Vol.21 (2), p.56-62

2013

Volltextzugriff (PDF)

Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine

Bioorganic & medicinal chemistry letters, 2012-11, Vol.22 (21), p.6642-6646

2012

Volltextzugriff (PDF)

Human Immunodeficiency Virus Mutagenesis during Antiviral Therapy: Impact of Drug-Resistant Reverse Transcriptase and Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors on Human Immunodeficiency Virus Type 1 Mutation Frequencies

Journal of Virology, 2005-09, Vol.79 (18), p.12045-12057

2005

Volltextzugriff (PDF)

Critical Role of the Human T-Cell Leukemia Virus Type 1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly

Journal of virology, 2018-07, Vol.92 (14)

2018

Volltextzugriff (PDF)

Role of the Human T-Cell Leukemia Virus Type 1 PTAP Motif in Gag Targeting and Particle Release

Journal of Virology, 2006-04, Vol.80 (7), p.3634-3643

2006

Volltextzugriff (PDF)

Concomitant Lethal Mutagenesis of Human Immunodeficiency Virus Type 1

Journal of molecular biology, 2012-06, Vol.419 (3-4), p.158-170

2012

Volltextzugriff (PDF)

Combination of Drugs and Drug-Resistant Reverse Transcriptase Results in a Multiplicative Increase of Human Immunodeficiency Virus Type 1 Mutant Frequencies

Journal of Virology, 2002-09, Vol.76 (18), p.9253-9259

2002

Volltextzugriff (PDF)

Rapid Determination of HIV-1 Mutant Frequencies and Mutation Spectra Using an mCherry/EGFP Dual-Reporter Viral Vector

Methods in molecular biology (Clifton, N.J.), 2016, Vol.1354, p.71

2016

Volltextzugriff (PDF)

5,6-Dihydro-5-aza-2′-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors

Bioorganic & medicinal chemistry, 2013-11, Vol.21 (22), p.7222-7228

2013

Volltextzugriff (PDF)

Analysis of Bovine Leukemia Virus Gag Membrane Targeting and Late Domain Function

Journal of Virology, 2002-08, Vol.76 (16), p.8485-8493

2002

Volltextzugriff (PDF)

The Interaction of Vpr with Uracil DNA Glycosylase Modulates the Human Immunodeficiency Virus Type 1 In Vivo Mutation Rate

Journal of Virology, 2000-08, Vol.74 (15), p.7039-7047

2000

Volltextzugriff (PDF)

In Vivo Analysis of Human T-Cell Leukemia Virus Type 1 Reverse Transcription Accuracy

Journal of Virology, 2000-10, Vol.74 (20), p.9525-9531

Mansky, L M

2000

Volltextzugriff (PDF)

3′-Azido-3′-Deoxythymidine (AZT) and AZT-Resistant Reverse Transcriptase Can Increase the In Vivo Mutation Rate of Human Immunodeficiency Virus Type 1

Journal of Virology, 2000-10, Vol.74 (20), p.9532-9539

2000

Volltextzugriff (PDF)

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

Journal of Virology, 1995-08, Vol.69 (8), p.5087-5094

1995

Volltextzugriff (PDF)

Retrovirus mutation rates and their role in genetic variation

Journal of general virology, 1998-06, Vol.79 ( Pt 6) (6), p.1337-1345

Mansky, L M

1998

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

ThemaMutation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Viral Mutation Rates

Exploiting Drug Repositioning for Discovery of a Novel HIV Combination Therapy

The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations

Development of a User-Friendly Pipeline for Mutational Analyses of HIV Using Ultra-Accurate Maximum-Depth Sequencing

Vpr-mediated Incorporation of UNG2 into HIV-1 Particles Is Required to Modulate the Virus Mutation Rate and for Replication in Macrophages

Retroviral vectors for analysis of viral mutagenesis and recombination

Differential Activity of APOBEC3F, APOBEC3G, and APOBEC3H in the Restriction of HIV-2

Structural Insights into the Mechanism of Human T-cell Leukemia Virus Type 1 Gag Targeting to the Plasma Membrane for Assembly

Influence of Reverse Transcriptase Variants, Drugs, and Vpr on Human Immunodeficiency Virus Type 1 Mutant Frequencies

Interrelationship between HIV-1 Fitness and Mutation Rate

Back to the future: revisiting HIV-1 lethal mutagenesis

Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine

Human Immunodeficiency Virus Mutagenesis during Antiviral Therapy: Impact of Drug-Resistant Reverse Transcriptase and Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors on Human Immunodeficiency Virus Type 1 Mutation Frequencies

Critical Role of the Human T-Cell Leukemia Virus Type 1 Capsid N-Terminal Domain for Gag-Gag Interactions and Virus Particle Assembly

Role of the Human T-Cell Leukemia Virus Type 1 PTAP Motif in Gag Targeting and Particle Release

Concomitant Lethal Mutagenesis of Human Immunodeficiency Virus Type 1

Combination of Drugs and Drug-Resistant Reverse Transcriptase Results in a Multiplicative Increase of Human Immunodeficiency Virus Type 1 Mutant Frequencies

Rapid Determination of HIV-1 Mutant Frequencies and Mutation Spectra Using an mCherry/EGFP Dual-Reporter Viral Vector

5,6-Dihydro-5-aza-2′-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors

Analysis of Bovine Leukemia Virus Gag Membrane Targeting and Late Domain Function

The Interaction of Vpr with Uracil DNA Glycosylase Modulates the Human Immunodeficiency Virus Type 1 In Vivo Mutation Rate

In Vivo Analysis of Human T-Cell Leukemia Virus Type 1 Reverse Transcription Accuracy

3′-Azido-3′-Deoxythymidine (AZT) and AZT-Resistant Reverse Transcriptase Can Increase the In Vivo Mutation Rate of Human Immunodeficiency Virus Type 1

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

Retrovirus mutation rates and their role in genetic variation

Aktive Filter

Suchergebnisse filtern